Physician Selected Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
Primary Objective
To evaluate the overall response rate achieved with physician s choice selinexor-based combination therapy
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Peter Forsberg, MD
Study ID
Protocol Number: 20-2202
More information available at ClinicalTrials.gov: NCT04925193
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers